ObvioHealth Appoints Two New Company Executives
New hires expected to reinforce the company's clinical and digital trial expertise.
ObvioHealth, a virtual research organization (VRO), has announced the appointmet of John Cassidy as chief financial officer and Florence Mowlem as VP of science. Previously, Cassidy served as the global head of product and commercial for eClinical at LabCorp while Mowlem joins ObvioHealth after working for Medable, where she led a team driving the implementation of electronic clinical outcomes assessments (eCOAs).
"ObvioHealth has a unique model blending clinical expertise with a robust platform to deliver stronger evidence and accelerated timelines for drug development," said Cassidy, in a company press release. "It is the perfect time to join this experienced team to help bring the business to a new level of growth."
Reference: ObvioHealth Strengthens Leadership Team with Key Industry Appointments. PR Newswire. October 17, 2023. Accessed October 19, 2023. https://www.prnewswire.com/news-releases/obviohealth-strengthens-leadership-team-with-key-industry-appointments-301956006.html
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
